S, W., & X, L. (2020). CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press.
Chicago Style (17th ed.) CitationS, Wang, and Liu X. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press, 2020.
MLA (8th ed.) CitationS, Wang, and Liu X. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.